Editorial Comment: Solifenacin treatment after intradetrusor injections with botulinum toxin in patients with neurogenic detrusor overactivity | Int. braz. j. urol;48(6): 988-989, Nov.-Dec. 2022. | LILACS

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Editorial Comment: Solifenacin treatment after intradetrusor injections with botulinum toxin in patients with neurogenic detrusor overactivity

Averbeck, Marcio Augusto.

Affiliation

Averbeck, Marcio Augusto; Unidade de Videourodinâmica. Hospital Moinhos de Vento. Chefe de Neuro-Urologia. Porto Alegre. BR

Int. braz. j. urol ; 48(6): 988-989, Nov.-Dec. 2022.

Article in En | LILACS | ID: biblio-1405158

Responsible library: BR1.1

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: LILACS Main subject: Urinary Bladder, Neurogenic / Botulinum Toxins / Botulinum Toxins, Type A / Urinary Bladder, Overactive / Neuromuscular Agents Limits: Humans Language: En Journal: Int. braz. j. urol Journal subject: UROLOGIA Year: 2022 Document type: Article Affiliation country: Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: LILACS Main subject: Urinary Bladder, Neurogenic / Botulinum Toxins / Botulinum Toxins, Type A / Urinary Bladder, Overactive / Neuromuscular Agents Limits: Humans Language: En Journal: Int. braz. j. urol Journal subject: UROLOGIA Year: 2022 Document type: Article Affiliation country: Country of publication: